Newron Pharmaceuticals S.p.A. (SWX: NWRN)
Switzerland
· Delayed Price · Currency is CHF
8.81
-0.14 (-1.56%)
Jan 3, 2025, 5:31 PM CET
Newron Pharmaceuticals Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -18.83 | -16.22 | -17.49 | -14.9 | -21 | -20.21 | |
| Depreciation & Amortization | 0.2 | 0.2 | 0.2 | 0.21 | 0.22 | 0.21 | |
| Stock-Based Compensation | 0.31 | 0.2 | 0.48 | 0.76 | 1.46 | 2.13 | |
| Other Operating Activities | 2.92 | 4.17 | 3.83 | 2.75 | 0.01 | -4.64 | |
| Change in Accounts Receivable | -0.72 | -1.31 | -0.88 | 1.75 | 1.23 | -0.16 | |
| Change in Accounts Payable | 0.61 | 0.58 | 0.58 | -3.95 | 0.56 | 0.71 | |
| Change in Other Net Operating Assets | 2.14 | 2.24 | 2.19 | 1.93 | 1.94 | -0.01 | |
| Operating Cash Flow | -13.37 | -10.14 | -11.09 | -11.45 | -15.59 | -21.98 | |
| Capital Expenditures | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.05 | |
| Sale (Purchase) of Intangibles | - | - | - | - | -0 | - | |
| Investment in Securities | 5.28 | 3.26 | -0.3 | 8.44 | -0.58 | -0.88 | |
| Investing Cash Flow | 5.27 | 3.25 | -0.32 | 8.42 | -0.62 | -0.93 | |
| Long-Term Debt Issued | - | - | - | 15 | 7.5 | 17.5 | |
| Long-Term Debt Repaid | - | -0.19 | -0.19 | -0.17 | -0.14 | -0.16 | |
| Net Debt Issued (Repaid) | -0.19 | -0.19 | -0.19 | 14.83 | 7.37 | 17.34 | |
| Issuance of Common Stock | 8.65 | - | - | - | - | - | |
| Other Financing Activities | -0.17 | - | - | - | - | - | |
| Financing Cash Flow | 8.28 | -0.19 | -0.19 | 14.83 | 7.37 | 17.34 | |
| Net Cash Flow | 0.18 | -7.09 | -11.6 | 11.81 | -8.84 | -5.57 | |
| Free Cash Flow | -13.38 | -10.15 | -11.11 | -11.47 | -15.62 | -22.03 | |
| Free Cash Flow Margin | -191.89% | -112.08% | -182.31% | -198.98% | -297.11% | -312.97% | |
| Free Cash Flow Per Share | -0.73 | -0.57 | -0.62 | -0.64 | -0.88 | -1.23 | |
| Cash Interest Paid | 1.53 | 1.2 | 1.23 | 0.87 | 0.61 | 0.06 | |
| Levered Free Cash Flow | -11.36 | -9.22 | -9.64 | -10.04 | -10.14 | -0.55 | |
| Unlevered Free Cash Flow | -8.66 | -6.61 | -7.17 | -8.22 | -8.74 | -0.2 | |
| Change in Net Working Capital | -0.22 | -0.27 | -0.48 | 1.45 | -0.91 | -10.59 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.